Hikari Power’s AbbVie ABBV Stock Holding History

Hikari Power’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-53,543	Closed	-$12.2M	–	52
2025 Q4	$12.2M	Hold	53,543	–	–	0.96%	17
2025 Q3	$12.4M	Hold	53,543	–	–	1%	17
2025 Q2	$9.94M	Hold	53,543	–	–	0.83%	19
2025 Q1	$11.2M	Hold	53,543	–	–	0.89%	16
2024 Q4	$9.52M	Hold	53,543	–	–	0.82%	20
2024 Q3	$10.6M	Hold	53,543	–	–	0.88%	18
2024 Q2	$9.18M	Hold	53,543	–	–	0.83%	21
2024 Q1	$9.75M	Hold	53,543	–	–	0.84%	20
2023 Q4	$8.3M	Hold	53,543	–	–	0.79%	24
2023 Q3	$7.98M	Hold	53,543	–	–	0.78%	24
2023 Q2	$7.21M	Hold	53,543	–	–	0.69%	27
2023 Q1	$8.53M	Hold	53,543	–	–	0.86%	24
2022 Q4	$8.65M	Hold	53,543	–	–	0.85%	25
2022 Q3	$7.19M	Hold	53,543	–	–	0.8%	25
2022 Q2	$8.2M	Hold	53,543	–	–	0.88%	25
2022 Q1	$8.68M	Buy	53,543 +630	+1%	+$91.5K	0.78%	25
2021 Q4	$7.16M	Buy	52,913 +3,950	+8%	+$467K	0.67%	27
2021 Q3	$5.28M	Buy	48,963 +5,850	+14%	+$668K	0.53%	32
2021 Q2	$4.86M	Buy	43,113 +19,140	+80%	+$2.16M	0.48%	33
2021 Q1	$2.59M	Buy	23,973 +10,050	+72%	+$1.07M	0.27%	37
2020 Q4	$1.49M	Buy	13,923 +4,830	+53%	+$464K	0.17%	42
2020 Q3	$796K	Hold	9,093	–	–	0.1%	48
2020 Q2	$893K	Buy	+9,093	New	+$801K	0.12%	47
2020 Q1	–	Sell	-2,440	Closed	-$216K	–	85
2019 Q4	$216K	Buy	+2,440	New	+$203K	0.02%	95
2016 Q4	–	Sell	-84,300	Closed	-$5.32M	–	49
2016 Q3	$5.32M	Hold	84,300	–	–	0.63%	39
2016 Q2	$5.22M	Sell	84,300 -34,000	-29%	-$2.07M	0.6%	40
2016 Q1	$6.76M	Buy	118,300 +46,600	+65%	+$2.6M	0.78%	35
2015 Q4	$4.25M	Buy	71,700 +6,700	+10%	+$386K	0.58%	37
2015 Q3	$3.54M	Sell	65,000 -3,500	-5%	-$228K	0.59%	30
2015 Q2	$4.6M	Sell	68,500 -12,100	-15%	-$790K	0.69%	26
2015 Q1	$4.72M	Sell	80,600 -7,000	-8%	-$423K	0.67%	26
2014 Q4	$5.77M	Sell	87,600 -12,700	-13%	-$801K	0.81%	25
2014 Q3	$5.79M	Hold	100,300	–	–	0.86%	25
2014 Q2	$5.66M	Hold	100,300	–	–	0.82%	25
2014 Q1	$5.16K	Buy	+100,300	New	+$5.07M	0.63%	25

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hikari Power's ABBV Position: Q1 2026 in Review

Hikari Power sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 53,543 shares — an estimated $12.2M sold.

Hikari Power first reported a position in ABBV in Q1 2014 and held it in 35 quarters. The position peaked at $12.4M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Hikari Power reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
Hikari Power sold 53,543 AbbVie shares in Q1 2026, an estimated $12.2M.
Hikari Power first reported a position in AbbVie in Q1 2014 and held it in 35 quarters.
Hikari Power's AbbVie position peaked at $12.4M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Hikari Power's 13F filing for Q1 2026, filed 30 Apr 2026.